)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Biocytogen Pharmaceuticals Beijing
Biocytogen Pharmaceuticals Beijing (2315) investor relations material
Biocytogen Pharmaceuticals Beijing Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Oct, 2026
Executive summary
9M revenue RMB1,402.8m, up 49.09% YoY; net profit attributable to shareholders RMB312.45m, up 173.77%, and adjusted net profit RMB235.49m, up 307.62%.
Q3 revenue RMB461.37m, up 44.22% YoY; attributable net profit RMB71.36m, up 7.91%, and adjusted net profit RMB38.04m, up 30.19%.
Financial highlights
9M operating profit RMB325.93m vs RMB129.68m in 2025; total profit RMB325.55m vs RMB129.08m; net profit RMB312.45m vs RMB114.13m.
Non-recurring profit or loss totaled RMB76.96m for 9M and RMB33.32m for Q3, mainly from fair-value changes and disposals of biological assets and structured deposits.
Segment performance
Growth in pharmacology and efficacy services and animal models was cited as the main driver of revenue growth in Q3 and across 9M.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Biocytogen Pharmaceuticals Beijing
- Revenue rose 25.6%, net loss narrowed 73.3%, and operating cash flow turned positive.2315
H1 2024 - Revenue growth and cost discipline drove a return to profit and positive operating cash flow.2315H2 2024
- Revenue rose 51.3% as earnings and operating cash flow turned positive.2315H1 2025
- Revenue surged 40.6%, profit more than quintupled, and A-share proceeds expanded capacity.2315H2 2025
- Revenue rose 51.6%, while net profit increased more than fivefold on strong model and antibody growth.2315H1 2026
- Revenue surged 73.68% and net profit attributable to shareholders reached RMB104.0m.2315Q1 2026
Next Biocytogen Pharmaceuticals Beijing earnings date
H2 202625 Mar, 2027
Biocytogen Pharmaceuticals Beijing
Next Biocytogen Pharmaceuticals Beijing earnings date
H2 202625 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)